DUALITYBIO-B

9606
97.3004.79% ( -4.900 )
Delay Closed: Nov 16, 16:08:11

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: DUALITYBIO-B(09606) the Revenue is 126.67 M (-81.19%);the EBIT is -529.82 M (-932.4%);the EPS is -5.87 (+78.45%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.13B81.19%
----
----
EBIT
-0.53B932.37%
----
----
EPS
-5.871778.45%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 27, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly